Filters

Clear all

Expert Opinion

Plain Language Summary

Expert Review

Clinical Imbalances

Immune and inflammation

Gastro-intestinal

Modifiable Lifestyle Factors

Diet

Laboratory Testing

Blood

Text Availability

Abstract

Full text

Free full text

Publication Types

Journal Article

Research Support, Non-U.S. Gov't

Randomized Controlled Trial

Review

Research Support, N.I.H., Extramural

Clinical Trial

Multicenter Study

Meta-Analysis

Systematic Review

Comparative Study

Controlled Clinical Trial

Case Reports

Research Support, N.I.H., Intramural

Research Support, U.S. Gov't, Non-P.H.S.

Letter

Clinical Trial, Phase II

Comment

Observational Study

Scoping Review

Publication Year

From

Quick links

Individual year

2026

2025

2024

2023

2022

2021

2020

2019

2018

2017

2016

2015

2014

2013

2012

2011

2010

2009

2008

2007

2006

2005

2004

2003

2001

Sort by:

selected

Print page

Email selected articles

Favourite selected articles

Create a NED Search Alert for this search

Save this search

Advanced Search

Run an advanced search

Results for

""Interleukin 1 Receptor Antagonist Protein""[mesh_terms]

98 Results

Searching titles within these results

Granzyme B is elevated in esophageal biopsies from children with eosinophilic esophagitis.

Helena Thulin, Jesper Säfholm, Joachim Lundahl, Viktor Jovic, Mikael Adner, Caroline Nilsson

Journal of pediatric gastroenterology and nutrition 2024;78(2):313-319

Full Text

Abstract

Biologics in the treatment of calcium pyrophosphate deposition disease: a systematic literature review.

Edoardo Cipolletta, Andrea Di Matteo, Anna Scanu, Martina Isidori, Jacopo Di Battista, Leonardo Punzi, Walter Grassi, Emilio Filippucci

Clinical and experimental rheumatology 2020;38(5):1001-1007

Free Full Text

Abstract

Treatment of acute CPP crystal arthritis: What are we missing? Comment on: "Anakinra compared to prednisone in the treatment of acute CPPD crystal arthritis: A randomized controlled double-blinded pilot study" by Dumusc A. et al. Joint Bone Spine. 2020;88:105088.

Emilio Filippucci, Walter Grassi, Andrea Di Matteo, Edoardo Cipolletta

Joint bone spine 2023;88(5):105217

Full Text

New Insights into Pericarditis: Mechanisms of Injury and Therapeutic Targets.

Paul C Cremer, Serge C Harb, Bo Xu

Current cardiology reports 2017;19(7):60

Full Text

Abstract

The role of Interleukin-1 receptor antagonist as a treatment option in calcium pyrophosphate crystal deposition disease.

Nicola Maruotti, Francesco Paolo Cantatore, Daniela Cici, Addolorata Corrado, Alberto Altomare

Molecular biology reports 2021;48(5):4789-4796

Free Full Text

Abstract

Anakinra compared to prednisone in the treatment of acute CPPD crystal arthritis: A randomized controlled double-blinded pilot study.

Alexander So, Bérengère Aubry-Rozier, Pascal Zufferey, Charles Benaim, Borbala Pazar Maldonado, Alexandre Dumusc

Joint bone spine 2021;88(2):105088

Full Text

Therapeutic role of interleukin-1 receptor antagonist in pancreatic diseases: mendelian randomization study.

Shuai Yuan, Yuyang Miao, Xixian Ruan, Jie Chen, Xue Li, Susanna C Larsson

Frontiers in immunology 2023;14():1240754

Free Full Text

Abstract

Randomized trial of anakinra plus zinc vs. prednisone for severe alcohol-associated hepatitis.

Mack C Mitchell, Samer Gawrieh, Gyongyi Szabo, Wanzhu Tu, Patrick S Kamath, Arun J Sanyal, Srinivasan Dasarathy, Ramon Bataller, Qing Tang, Craig J McClain, Vijay H Shah, Svetlana Radaeva, Laura E Nagy, Bruce Barton, Naga P Chalasani

Journal of hepatology 2024;80(5):684-693

Free Full Text

Abstract

Migratory and intermittent polyarthritis as an atypical presentation of carnitine palmitoyltransferase II deficiency with positive response to treatment with Interleukin-1 receptor antagonist: a case presentation and case-based review.

Zacharias Raptopoulos, Savvas Psarelis, Konstantinos Parperis

Rheumatology international 2025;45(7):161

Full Text

Abstract

Molecular genetics of febrile seizures.

Junko Nakayama, Tadao Arinami

Epilepsy research 2006;70 Suppl 1():S190-8

Full Text

Abstract

Efficacy and safety of anakinra and canakinumab in PSTPIP1-associated inflammatory diseases: a comprehensive scoping review.

Francisco Gómez-García, Pedro Jesús Gómez-Arias, Ana Montilla-López, Jesús Gay-Mimbrera, Juan Ruano, Beatriz Isla-Tejera, Esmeralda Parra-Peralbo, Juan Luis Sanz-Cabanillas

Frontiers in immunology 2024;14():1339337

Free Full Text

Abstract

Placental secretion of interleukin-1 and interleukin-1 receptor antagonist in preeclampsia: effect of magnesium sulfate.

Alaa Amash, Gershon Holcberg, Olga Sapir, Mahmoud Huleihel

Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research 2013;32(9):432-41

Free Full Text

Abstract

Systematic review and meta-analysis of the associations of vegan and vegetarian diets with inflammatory biomarkers.

Knut Mai, Ronald Biemann, Afraa Jabakhanji, Juliane Menzel, Klaus Abraham, Cornelia Weikert

Scientific reports 2021;10(1):21736

Plain Language Summary

Free Full Text

Abstract

Interleukin-1 receptor antagonist, interleukin-2 receptor alpha subunit and amyotrophic lateral sclerosis.

S C Larsson, P M Roos, S Yuan

European journal of neurology 2021;27(10):1913-1917

Full Text

Abstract

Use of Anakinra in Hospitalized Patients with Crystal-associated Arthritis.

Gregory C Gardner, Jean W Liew

The Journal of rheumatology 2020;46(10):1345-1349

Full Text

Abstract

Results: 1 – 15 / 98

Filters

Expert Opinion

Clinical Imbalances

Modifiable Lifestyle Factors

Laboratory Testing

Text Availability

Publication Types

Publication Year

Results for ""Interleukin 1 Receptor Antagonist Protein""[mesh_terms]

Granzyme B is elevated in esophageal biopsies from children with eosinophilic esophagitis.

Biologics in the treatment of calcium pyrophosphate deposition disease: a systematic literature review.

Treatment of acute CPP crystal arthritis: What are we missing? Comment on: "Anakinra compared to prednisone in the treatment of acute CPPD crystal arthritis: A randomized controlled double-blinded pilot study" by Dumusc A. et al. Joint Bone Spine. 2020;88:105088.

New Insights into Pericarditis: Mechanisms of Injury and Therapeutic Targets.

The role of Interleukin-1 receptor antagonist as a treatment option in calcium pyrophosphate crystal deposition disease.

Anakinra compared to prednisone in the treatment of acute CPPD crystal arthritis: A randomized controlled double-blinded pilot study.

Therapeutic role of interleukin-1 receptor antagonist in pancreatic diseases: mendelian randomization study.

Randomized trial of anakinra plus zinc vs. prednisone for severe alcohol-associated hepatitis.

Migratory and intermittent polyarthritis as an atypical presentation of carnitine palmitoyltransferase II deficiency with positive response to treatment with Interleukin-1 receptor antagonist: a case presentation and case-based review.

Molecular genetics of febrile seizures.

Efficacy and safety of anakinra and canakinumab in PSTPIP1-associated inflammatory diseases: a comprehensive scoping review.

Placental secretion of interleukin-1 and interleukin-1 receptor antagonist in preeclampsia: effect of magnesium sulfate.

Systematic review and meta-analysis of the associations of vegan and vegetarian diets with inflammatory biomarkers.

Interleukin-1 receptor antagonist, interleukin-2 receptor alpha subunit and amyotrophic lateral sclerosis.

Use of Anakinra in Hospitalized Patients with Crystal-associated Arthritis.

Results for

""Interleukin 1 Receptor Antagonist Protein""[mesh_terms]